《微创化胰腺手术:布雷西亚国际循证指南》解读

Interpretation of"The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery(EGUMIPS)"

近十年,微创化胰腺手术技术飞速发展,已成为当今胰腺手术的重要组成部分。微创时代背景下,如何指导术者规范操作,将手术风险降至最低等临床难题成为亟需攻克的难关。继2019年Miami共识之后,更为权威的欧洲《微创化胰腺手术:布雷西亚国际循证指南》应运而生。其主要包含专业术语制订、手术指征评估、高危患者选择、术中操作要点等八大领域,其结合最新文献,在各项领域内提出较权威的推荐意见,体现微创化胰腺手术的现状及研究进展。

In the past decade,the technology of minimally invasive pancreatic surgery(MIPS)has developed rapidly,and now has become an important part of pancreatic surgery.In the context of the minimally invasive era,how to guide surgeons to operate in a standardized manner and minimize the surgical risks has become an urgent difficulty to be overcome.Following the 2019 Miami consensus,a more authoritative European guideline for MIPS,The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery,has emerged.The Brescia Guideline mainly includes eight fields,such as professional terminology formulation,surgical indication evaluation,selection of high‑risk patients,and key points of intraoperative operation.Combined with the latest literature,the Brescia Guideline puts forward authoritative recommendations in various fields and reflects the status quo and research progress of MIPS.